Laser Assisted Therapies and Immunotherapies for Oncology
Assisted Laser Therapies and Immunotherapies for Oncology
Professor Vanderlei Salvador Bagnato has a PhD from MIT (1987). He graduated with Honors, at the same time, in Materials Engineering (Federal University of São Carlos - Brazil - 1981) and in [...]
Visit of Prof. Bréchet to northern france branch of the CEA to discuss relationships with local actors in research and innovation
Following the success of the PhoS-Istos European project, MBD Texinov will propose a commercial solution for the treatment of actinic keratoses by PDT.
This special issue dedicated to the photodynamic therapy presents 3 studies led by the OncoThAI laboratory.
On the occasion of Véronique Fresnel's sporting achievement, Prof. Arnaud Scherpereel described the various progress made in the treatment of malignant pleural mesothelioma.
After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial
This phase II clinical trial aims to treat actinic keratosis with photodynamic therapy.
Presentation of light emiting frabrics for the photodynamic treatment of actinic keratosis.
Save the date: Update PDT-PDD 2020 will be held in Nancy, France!
OncoThAI attended the European Photodynamic Therapy and Photodiagnosis Update conference from September 18th to 22nd 2018 in Kochel (Germany)
OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord
The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal
The INDYGO clinical trial presented during the annual EANS meeting
On November 8th and 9th, 2018, the Cancéropole Nord-Ouest organized the second edition of the "Translationnelles" days: "Ovarian cancer - from biology to clinic" in Caen, France.
The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.
Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission
Third place for OncoThAI
The thesis project "Design of a light emitting fabric dedicated to intracavitary photodynamic therapy" received a favorable opinion from the ANRT for CIFRE funding.
Program of the day of January 29, 2019
OncoThAI will attend the 18th Congress of the European Society for Photodynamic Therapy in Brussels, France On March 8th and 9th 2019.
OncoThAI will attend the next International Photodynamic Association world congress in Boston and will present 14 papers introducing the most recent results of the lab.
Martha Baydoun, a postdoctoral fellow, has been selected by the call for projects Mobility to develop this research.
The thesis project "Development of a light emitting fabric for the treatment of peritoneal carcinomatosis of ovarian origin by intracavitary photodynamic therapy" received the favorable opinion of [...]
Matthieu DURAND, Urologist, defended his thesis entitled "EX VIVO 7 TESLA EXPERIMENTAL IMAGING OF LOCALIZED CANCER OF THE PROSTATE" on July 9, 2019.
This day will be held in Lille on November 28, 2019.
The first patient with Paget's disease has been treated by the PAGETEX clinical protocol.
Pr. Nicolas Reyns will present our latest breakthroughs in the glioblastoma treatment.
Under the chairmanship of Professor Pierre COLLINET, this congress will propose a program combining the fundamentals of surgery with the most striking innovations.
Her thesis deals with the use of photodynamic therapy in dermatology.
Congratulations to Ludivine LARUE, Isabelle TOUBIA and Mathilde CHAMPEAU for their brilliant presentations of their research work.
An Inserm delegation will be present on Thursday 12 December 2019 in the laboratory premises.
Prof. Mortier presented this technology on Europe 1 radio
Under the denomination "Laser Assisted Therapies and Immunotherapies for Oncology”
"Diagnostic and therapeutic strategies for intracranial vascular pathologies"
At the request of the CEO of Inserm, the laboratory will be closed for an indefinite period.
The revolution of immuno-oncology therapy: review of immune checkpoint inhibitors efficacy & specificities for the physicians